Alcator Advisory Group provides management teams and boards of life sciences companies with focused guidance and executive leadership experience to help catalyze their advancement and success. Our team of seasoned business consultants leverages their deep industry acumen to provide tailored solutions that drive growth and innovation.
C-Mod holds the world record for the highest volume average plasma pressure in a magnetic confinement device, which is an important metric for fusion reactor performance. The pioneering work and results of this fusion reactor prototype have substantially advanced the potential for fusion reactor energy, at a commercial scale, to usher in a transformative, post-fossil fuel, global energy standard in the coming decades.
At over 100 million degrees Celsius and immense gravitational pressure, the Magic happens … In a Fusion reaction, matter is transformed and an enormous amount of heat and light are released. At Alcator, we partner with our Clients to bring the Magic of Fusion to energize their business and leadership team.
James is a distinguished, innovation-focused Biotechnology Executive with 25+ year portfolio of success driving operations, business development, capital fundraising, intellectual property (IP), commercialization, and strategic planning across the life sciences & biotechnology sectors. He has extensive expertise in early stage oncology therapeutic and diagnostic ventures, including the fields of predictive/companion molecular diagnostics, proteomics and genomics, and development of novel cancer therapeutics. He most recently served as Chief Executive Officer of Allarity Therapeutics, Inc., and, during his 10 year tenure with the company, previously served as its Chief Business Officer and SVP of Corporate Development. Earlier in his career, he co-founded and led Paradigm Oncology, Inc. and Halcyon Diagnostics, Inc., both focused on development of oncology predictive diagnostics, and prior to that served as Director of Business Development at Enzymatics, Inc., and Chief Counsel at Cell Signaling Technology, Inc. James started his professional career as a bench biochemist conducting viral/diagnostic research at both Chiron Corporation and the J. David Gladstone Institutes. He is a registered patent attorney and studied toxicology at the Colorado State University at Ft. Collins and biochemistry at the University of California at Davis.